Antibiotics for Ear Infections

(MEASURE Trial)

Not yet recruiting at 4 trial locations
JL
Overseen ByJane Luce, MPH
Age: < 18
Sex: Any
Trial Phase: Phase 4
Sponsor: Nader Shaikh
Prior Safety DataThis treatment has passed at least one previous human trial

What You Need to Know Before You Apply

What is the purpose of this trial?

This study is being conducted at multiple hospitals and clinics to better understand whether antibiotics truly help children feel better when they have an ear infection (acute otitis media). Children in the study are randomly assigned (like flipping a coin) to receive either amoxicillin, amoxicillin-clavulanate, or a placebo (a look-alike medicine with no active antibiotic). Neither families nor study staff know which treatment the child is receiving during the study. The main goal is to compare how severe children's symptoms are each day while on these treatments. Parents or caregivers will report symptoms daily using a simple electronic diary. The study will also look at whether certain factors such as how sick the child is at the start, presence of fever, age, or how well antibiotics work. The results will help guide better treatment decisions for children with ear infections.

Who Is on the Research Team?

NS

Nader Shaikh, MD

Principal Investigator

University of Pittsburgh

Are You a Good Fit for This Trial?

This trial is for children with ear infections, including middle ear infection (acute otitis media) and swimmer's ear. Children who are otherwise healthy and able to take oral medicine can participate. Those with severe illness or allergies to study medicines may not be eligible.

Inclusion Criteria

I have been diagnosed with acute middle ear infection.
I am between 6 months and 3 years old.

Exclusion Criteria

Previous randomization into either MEASURE trial within the last 6 months
I had a burst eardrum with ear discharge when I first saw the doctor.
I have taken antibiotics within the past 7 days.
See 13 more

What Are the Treatments Tested in This Trial?

Interventions

  • Amoxicillin
  • Amoxicillin-Clavulanate

Trial Overview

The study compares three treatments: amoxicillin, amoxicillin-clavulanate (both antibiotics), and a placebo (inactive medicine). Children are randomly assigned to one group, and neither families nor doctors know which treatment is given until the end of the study.

How Is the Trial Designed?

4

Treatment groups

Active Control

Placebo Group

Group I: AmoxicillinActive Control1 Intervention
Group II: Amoxicillin-ClavulanateActive Control1 Intervention
Group III: Amoxicillin PlaceboPlacebo Group1 Intervention
Group IV: Amoxicillin-Clavulanate PlaceboPlacebo Group1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Nader Shaikh

Lead Sponsor

Trials
3
Recruited
1,200+

Patient-Centered Outcomes Research Institute

Collaborator

Trials
592
Recruited
27,110,000+